Atlas Trials

Phase 1 Food Effect Study for Alicaforsen Tablets

Clinical trial NCT03473626 · COMPLETED

Trial details

NCT number
NCT03473626
Sponsor
Atlantic Pharmaceuticals Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
IBD
Start date
2018-03-16
Primary completion
2018-04-06
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.